Salesforce, Inc. (NYSE:CRM) builds customer relationship management and enterprise cloud software used by the majority of the world's largest corporations. The stock has shed nearly a third of its value year to date, and attention is now fixed on whether its Agentforce AI platform can reverse that slide.
At a Glance
- CRM last traded at $153.32, down 0.04% on the day, with a 52-week range of $146.32 to $211.34
- Market cap stands at $125.65 billion; trailing P/E is 17.68 with EPS of $8.67
- Dividend yield is 1.15%; RSI of 33.58 places the stock in oversold territory
- Salesforce posted four consecutive earnings beats heading into its fiscal Q1 2027 report
- Full year fiscal 2027 revenue guidance calls for $45.8 billion to $46.2 billion, representing 10 to 11% growth
| Price | 153.32 USD |
|---|---|
| Day change | -0.06 (-0.04%) |
| 52-week range | 146.32 – 211.34 |
| Market cap | $125.65B |
| P/E ratio | 17.68 |
| EPS (ttm) | 8.67 |
| Dividend yield | 1.15% |
| RSI (14) | 33.58 |
| Volume | 7,918,934 |
Agentforce at the Center of Everything
No product in Salesforce's catalog carries more weight right now than Agentforce. For the past two quarters, the agentic AI platform has dominated earnings calls, product announcements and analyst conversations. The company's fiscal first quarter 2027 results, reported after the close on May 27 with a conference call at 5:00 PM ET, served as the next formal test of that thesis.
Wall Street had set the bar at $3.12 in earnings per share on $11.05 billion in revenue, up from $2.58 in the year ago quarter. Salesforce enters the print with $41.5 billion in annual revenue and a client roster that spans virtually every major global enterprise. The severity of the selloff, nearly 36% over the past twelve months, reflects investor doubt about whether Agentforce can grow at a pace that justifies the company's premium positioning as AI tools multiply across the industry.

The Q4 fiscal 2026 results, reported February 25, 2026, established the foundation for both the optimistic and skeptical readings of the stock. Agentforce ARR expanded 169% and reached $800 million. That number sounds dramatic until it is weighed against the company's overall $41.5 billion revenue base. From that base, $800 million in ARR requires sustained acceleration to meaningfully shift Salesforce's consolidated growth trajectory in the near term.
The metric most analysts are tracking is not whether Salesforce beats the top line. It is whether Agentforce deal count, ARR, and the number of production accounts maintained or extended the momentum established in Q4. Specifically, can Agentforce grow fast enough to offset the organic deceleration visible in the legacy CRM and Service Cloud businesses?
Capital Returns and the Valuation Debate
Salesforce returned $14.3 billion to shareholders in fiscal 2026: $12.7 billion through buybacks and $1.6 billion in dividends, funded by free cash flow of $14.4 billion. A company generating cash at that level while carrying a P/E of 17.68 is priced more for doubt than conviction, and the current share price near the bottom of its 52-week range reflects that mood precisely.
Full year guidance issued in February calls for revenue of $45.8 billion to $46.2 billion, with organic revenue reacceleration expected in the second half of the fiscal year. The longer term target of $63 billion in revenue by fiscal 2030 sits in the background of every valuation conversation.

What the Numbers Say
At 17.68 times trailing earnings, CRM trades at a meaningful discount to where it has historically been valued. For a company of this scale and cash generation, that multiple implies the market is embedding real skepticism about growth acceleration rather than assuming it will arrive on schedule.
The RSI of 33.58 places CRM in oversold territory by conventional technical measures, meaning the stock has absorbed consistent selling pressure without a meaningful relief rally. Sitting at $153.32, it is hovering just above its 52-week low of $146.32. The upper end of the 52-week range, $211.34, represents roughly 38% upside from the current price, which quantifies the gap between the skeptical and constructive scenarios.
The dividend yield of 1.15% is modest but meaningful given the buyback program's scale. Shareholders are receiving capital returns through both channels, and the free cash flow backing those returns, $14.4 billion in fiscal 2026, is not a speculative figure. It is the product of a mature, profitable software franchise.
Bull Case and Bear Case
The constructive argument is clean. If Agentforce maintains its ARR and deal count trajectory, and if the second half of fiscal 2027 delivers the organic revenue reacceleration the company has guided toward, then CRM at current levels looks materially undervalued relative to the $63 billion fiscal 2030 revenue target. The free cash flow profile and the buyback program provide support while investors wait for that thesis to develop.
The bearish reading is equally direct. If Agentforce deal growth stalls, or if competition from Microsoft Copilot and other AI native CRM tools intensifies, or if enterprise software budgets tighten under macroeconomic pressure, then the guidance looks optimistic rather than conservative. In that scenario, the stock's decline from $211.34 to $153.32 reflects rational repricing rather than an overcorrection. The four consecutive earnings beats offer some comfort, but they predate the period when AI competition became this concentrated.
Frequently Asked Questions
What is Agentforce and why does it matter to Salesforce's stock?
Agentforce is Salesforce's agentic AI platform, designed to automate complex business workflows across the company's cloud products. Investors are treating its adoption rate, specifically ARR and deal count growth, as the primary indicator of whether Salesforce can accelerate revenue beyond its legacy CRM and Service Cloud businesses.
Why has CRM stock fallen so sharply over the past year?
CRM is down approximately 36% over the past twelve months, reflecting investor concern that Agentforce adoption, while growing, remains too small a share of total revenue to reverse slowing organic growth in Salesforce's core products. Broader skepticism about enterprise AI monetization timelines has amplified the pressure.
What is Salesforce's current earnings and revenue guidance?
For fiscal 2027, Salesforce guided for revenue of $45.8 billion to $46.2 billion, representing 10 to 11% growth over fiscal 2026. The company expects organic revenue reacceleration in the second half of the fiscal year, with a longer term target of $63 billion by fiscal 2030.
Does Salesforce pay a dividend?
Yes. At the current share price of $153.32, CRM carries a dividend yield of 1.15%. In fiscal 2026, the company distributed $1.6 billion in dividends alongside $12.7 billion in share buybacks, supported by $14.4 billion in free cash flow.
Where the Stock Sits Heading Into the Print
CRM is trading near the floor of its annual range, carries an oversold RSI, and generates free cash flow that exceeds its entire market cap in roughly nine years at current rates. The May 27 earnings report will not settle the Agentforce debate permanently, but the ARR figure, deal count trajectory, and management's tone on second half reacceleration will sharpen the picture considerably. The numbers will either validate the skepticism that has driven this selloff or begin to erode it.



